Navigation Links
MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
Date:8/19/2007

s listed in the table below.

Teplizumab Clinical Trials

Study Brief Description Additional Information

Protege trial Global Phase 2/3 trial http://www.protegediabetes.com

for patients with http://www.clinicaltrials.gov

recent-onset type 1 (search for Protege)

diabetes mellitus (less

than or equal to 12

weeks from symptoms)

ages 8-35 with treatment

at the start of the

study and again at

six months

AbATE trial Led by Dr. Kevan Herold http://www.abatetrial.org

of Yale University, http://www.clinicaltrials.gov

this Phase 2 trial, (search for NCT00129259)

funded by the Immune

Tolerance Network and

NIAID, will evaluate

patients with recent-

onset type 1 diabetes

mellitus (less than

or equal to 6 weeks

from diagnosis) ages

8-30 with treatment at

the start of the study

and again at one year

Delay Study Led by Dr. Kevan Herold http://www.clinicaltrials.gov

of Yale University, (search for NCT00378508)

this Phase 2 trial funded

by NIDDK is for patients

ages 8-30 with type 1


'/>"/>

SOURCE MacroGenics, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
3. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
4. Global Rabies Treatment May be Possible with NanoViricides Drugs
5. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... FALLS, N.J. , March 5, 2015 CANTEL ... results for its second quarter ended January 31, 2015 on ... conference call to discuss the results at 11:00 AM ET. ... (877) 407-8033 approximately 5 to 10 minutes before the beginning ... digital replay of the call will be available from Thursday, ...
(Date:3/5/2015)... , March 5, 2015   AMC Health ... solutions recognized for improving the effectiveness and efficiency ... Robert Anazagasty and Jared Wilstead ... as Vice President, Strategic Client Development, and Wilstead ... additions support AMC Health,s commitment to accelerating the ...
(Date:3/5/2015)...  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... the approved abbreviated new drug application ("ANDA") for ... previously marketed by Teva Pharmaceuticals.  According to IMS ... approximately $39 million in 2014.   ... of ANI Pharmaceuticals, stated, "This acquisition further expands ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3
... Nostrum, a privately-held,company based in Edison, New ... its early, primate, proof-of-concept study for its,novel ... Nostrum,s,Symmetrix subsidiary, based in Singapore, is developing ... the Institute of Microbial,Technology, Chandigarh, India, which ...
... A new study funded by,Health Canada and other ... of the omega-3 DHA* and enhanced infant,development. The ... published in the Journal of Pediatrics, reveals DHA,consumed ... infant,s sensory,cognitive, and motor development., The research ...
Cached Medicine Technology:Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein 2Pregnant Women Need Omega-3 to Boost Infant Development 2
(Date:3/6/2015)... As the Association of American ... 90,000 doctors by 2025 is updated this week and ... is proactively preparing by analyzing demographics and pursuing viable ... , Several factors including the increasing number of retiring ... the Affordable Care Act and an uneven distribution of ...
(Date:3/6/2015)... First Choice Emergency Room opened its new Littleton ... 13351 W. Bowles Avenue, Littleton, Colorado and is open 24-7. ... provide the highest quality emergency medical care to the Littleton ... Emergency Room Littleton. , First Choice Emergency Room ... of Commerce and a medical community open house yesterday. ...
(Date:3/6/2015)... 2015 Magellan Rx Management’s 2014 Medical ... for key trends and statistics on one of the ... from Magellan Rx Management will discuss key findings from ... Hidden Specialty Drug Spend,” a complimentary March 19 webinar, ... Specialty drug spend makes up more than a quarter ...
(Date:3/6/2015)... In a new study conducted at a Warsaw ... shoulder pain was their first mesothelioma symptom. Surviving Mesothelioma has ... here to read it now. , Doctors at the ... 49 mesothelioma patients between 2006 and 2012 and ... pain that first prompted them to see a doctor. For ...
(Date:3/6/2015)... March 06, 2015 You Wealth ... created a unique ‘energy’ experiment to determine if ... , After quick ‘5 -7 minute’ remote ... 150+ countries reported their life improving - often ... positive results. , According to research, respondents saw ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2
... polio drive in this industrial city, thanks to lack of ... Uttar Pradesh health department staff who had to face the ... staff who went door-to-door to administer polio on May 21 ... their faces., ,Chief Medical Officer Vijay Shanker Singh said ...
... operation, a team of doctors here sucessfully removed a 'minute ... 11-month-old (RPT 11-month-old) boy. // ,Dr Palaniappan of ... perform the operation recently, told PTI here that Muniraj was ... food for the last one-and-a-half months., ,After trying different ...
... and Pharma Ltd today said it would raise 16 million ... investors. // ,The company would allot 16,000 FCCBs ... would be listed on the Singapore Stock Exchange, Ankur Drugs ... Fund Ltd would be allotted 14,000 FCCBs while 1,000 FCCBs ...
... transmission of the deadly bird flu virus among members of ... has sought to assure the public that potentially dangerous mutation ... maintained that human contagion cannot be ruled out in the ... far there has been no evidence that efficient human-to-human transmission ...
... has confirmed an outbreak of bird flu at a poultry ... on Thursday//. ,Timothy Obi, leader of the Avian ... (FAO), has told reporters that the institute claimed to have ... them to be infected with the deadly H5N1 virus. ...
... that has been announced states that all the state schools are ... onwards//. This is part of their drive against obesity. ... skimmed milk to pupils aged 3 to 18. The ruling also ... times, and to cartons sold in vending machines. ,This ...
Cached Medicine News:Health News:Fresh Outbreak Of Bird Flu In Nigeria 2Health News:All State Run Schools Are To Ban Whole Milk To Children 2Health News:All State Run Schools Are To Ban Whole Milk To Children 3
... Direct to High Res SSP kits provide high resolution ... Locus specific typing on a single tray reduces QC ... from genomic DNA to high resolution results, no need ... with a single tray , Unique reaction pattern for ...
... allele-specific primer combinations in the PCR amplification. ... only primers whose sequence is completely complementary ... by the polymerase into PCR products. In ... Using the Biotest SSP Kit Systems, reliable ...
... Plasma Storage Freezers HPF 125-4 incorporate ... a microprocessor-based independent temperature controller and ... and visual high temperature alarms help ... products. The LCD viewscreen is easy ...
Plasma Blast Chest Freezer -50C - 8098/8091 maintains a -50C (-58F) temperature to rapidly freeze single donor, apheresed, and fresh frozen plasma. Rapid freezing also preserves Factor VIII. Full loa...
Medicine Products: